"","pathway","pval","padj","log2err","NES","size","state","pvlabel"
"1","Extracellular matrix organization",9.28445000939025e-21,1.07838886859068e-17,1.1778932614942,-2.58385757205288,252,"down","***"
"2","Smooth Muscle Contraction",3.32905081615238e-09,4.07020265574841e-07,0.774939030136436,-2.51881802409956,33,"down","***"
"3","Degradation of the extracellular matrix",2.47554349817054e-11,5.75068754625017e-09,0.863415391606693,-2.43681079810305,116,"down","***"
"4","Post-translational protein phosphorylation",6.63995018824579e-10,1.02830695248633e-07,0.801215574617779,-2.42103956328364,78,"down","***"
"5","Cell-extracellular matrix interactions",3.59095942587089e-07,2.87648232630968e-05,0.674962860011025,-2.38893295268819,16,"down","***"
"6","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)",1.99650954508807e-09,2.72817157249388e-07,0.774939030136436,-2.36340611357918,88,"down","***"
"7","Platelet degranulation ",1.09007940181235e-09,1.58265903150631e-07,0.788186810800237,-2.33745839745346,103,"down","***"
"8","Elastic fibre formation",3.34557860311911e-07,2.77563539108775e-05,0.674962860011025,-2.32510773323975,41,"down","***"
"9","Collagen formation",1.50399125006104e-08,1.66370079709133e-06,0.73376198835648,-2.30091419883949,78,"down","***"
"10","Collagen degradation",4.33450683162651e-07,3.35635312328946e-05,0.674962860011025,-2.28970961456866,54,"down","***"
"11","Response to elevated platelet cytosolic Ca2+",5.78217393932031e-09,6.71599503052054e-07,0.761460801445585,-2.28577020030626,108,"down","***"
"12","Neutrophil degranulation",3.26069343016826e-17,1.51491816765618e-14,1.06720998682811,-2.25868056936855,394,"down","***"
"13","Semaphorin interactions",7.50867813575988e-07,5.28565433617279e-05,0.659444398037935,-2.2420795812423,60,"down","***"
"14","ECM proteoglycans",4.83255268221404e-07,3.62129673573652e-05,0.659444398037935,-2.2354288703799,62,"down","***"
"15","Integrin cell surface interactions",2.07590585919819e-07,1.85474204266054e-05,0.690132458796796,-2.22579779122972,77,"down","***"
"16","Collagen biosynthesis and modifying enzymes",7.83531981524092e-07,5.35336703847196e-05,0.659444398037935,-2.21616425595757,58,"down","***"
"17","Molecules associated with elastic fibres",7.75242213407574e-06,0.000473917805722577,0.593325476396405,-2.19687587148965,34,"down","***"
"18","RHO GTPases Activate ROCKs",3.50504798388521e-05,0.00159266749355368,0.557332238758646,-2.16201370745661,19,"down","**"
"19","Crosslinking of collagen fibrils",5.241513567809e-05,0.00221382473054915,0.557332238758646,-2.15257502764046,16,"down","**"
"20","Platelet activation, signaling and aggregation",2.87995652780732e-11,6.08194455826945e-09,0.863415391606693,-2.14550714719556,220,"down","***"
"21","Assembly of collagen fibrils and other multimeric structures",1.08064309608864e-05,0.000643675362106129,0.593325476396405,-2.13381497632986,53,"down","***"
"22","RHO GTPases activate CIT",6.86248392205063e-05,0.00279676318437257,0.538434096309916,-2.12369454286278,20,"down","**"
"23","Non-integrin membrane-ECM interactions",1.65825522904543e-05,0.00083741889066794,0.575610261071129,-2.10621562568823,49,"down","***"
"24","Laminin interactions",0.00014219860899475,0.00532786078540007,0.518848077743792,-2.06149399606387,28,"down","**"
"25","VEGF binds to VEGFR leading to receptor dimerization",3.56516184523424e-05,0.00159266749355368,0.557332238758646,-2.05463366234134,7,"down","**"
"26","VEGF ligand-receptor interactions",3.56516184523424e-05,0.00159266749355368,0.557332238758646,-2.05463366234134,7,"down","**"
"27","Leishmania infection",2.09174623958387e-08,2.20869387025151e-06,0.73376198835648,-2.05405009309611,187,"down","***"
"28","NR1H2 & NR1H3 regulate gene expression linked to lipogenesis",0.000115502730107797,0.00439857118099039,0.538434096309916,-2.03996292099121,8,"down","**"
"29","RHO GTPases activate PAKs",0.000282725713665684,0.00925030750486456,0.49849310876659,-2.01695279336186,22,"down","**"
"30","Innate Immune System",1.28520924756481e-19,9.95180360697688e-17,1.14219120216838,-2.01550044330256,814,"down","***"
"31","Hemostasis",1.82291451305542e-13,6.0494720197539e-11,0.943632225232838,-2.00465891772351,488,"down","***"
"32","Other semaphorin interactions",0.00066233487447678,0.0158618960145315,0.477270815362862,-1.99592443047611,18,"down","*"
"33","Sema4D induced cell migration and growth-cone collapse",0.000438742425015295,0.0127399831663816,0.49849310876659,-1.98399997562048,20,"down","*"
"34","Antigen processing-Cross presentation",1.36052172235343e-05,0.000752498085958813,0.593325476396405,-1.9818782023921,81,"down","***"
"35","Signal regulatory protein family interactions",0.0010665311639692,0.0233731310745326,0.45505986738723,-1.97280597682491,14,"down","*"
"36","RHO GTPases activate PKNs",0.000431759786951391,0.0127399831663816,0.49849310876659,-1.97155246919937,32,"down","*"
"37","L1CAM interactions",1.87216826233232e-05,0.000925329121999572,0.575610261071129,-1.96156343999436,96,"down","***"
"38","Sema4D in semaphorin signaling",0.000555567592120093,0.0145207489478578,0.477270815362862,-1.95507377659982,24,"down","*"
"39","Nervous system development",3.17646657793837e-12,9.22366482568855e-10,0.898671232061694,-1.95132986006241,491,"down","***"
"40","Cell surface interactions at the vascular wall",1.61544364104783e-05,0.00083741889066794,0.575610261071129,-1.94875804257067,105,"down","***"
"41","NR1H2 and NR1H3-mediated signaling",0.000211184310321235,0.00743304777085194,0.518848077743792,-1.94459246166198,39,"down","**"
"42","Chondroitin sulfate/dermatan sulfate metabolism",0.000239207217349475,0.00805330965076566,0.518848077743792,-1.94259170353879,41,"down","**"
"43","Signaling by VEGF",1.64098494955379e-05,0.00083741889066794,0.575610261071129,-1.94144357620421,99,"down","***"
"44","ROS and RNS production in phagocytes",0.000336672005564444,0.0107135488894,0.49849310876659,-1.9385758557335,31,"down","*"
"45","Signaling by Receptor Tyrosine Kinases",4.13046664366484e-11,7.3808261640257e-09,0.851339057116899,-1.93445801074054,451,"down","***"
"46","RHO GTPase Effectors",3.45393371399678e-08,3.48847305113675e-06,0.719512826338911,-1.93132301413601,234,"down","***"
"47","Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)",0.00182703037068824,0.0347884553369571,0.45505986738723,1.92937477215708,12,"up","*"
"48","Signaling by Rho GTPases",2.53395217113317e-09,3.27020605196798e-07,0.774939030136436,-1.92931460459968,347,"down","***"
"49","Axon guidance",1.57922996579864e-11,4.07616801172248e-09,0.863415391606693,-1.92497725508749,472,"down","***"
"50","Pre-NOTCH Processing in Golgi",0.000929800394848328,0.0211757482081634,0.477270815362862,-1.9178487651421,17,"down","*"
"51","Plasma lipoprotein assembly",0.00115645283321652,0.0246462379042384,0.45505986738723,-1.91467053666262,10,"down","*"
"52","Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)",0.00203585076443956,0.035827888831766,0.431707695803346,1.91300703583918,12,"up","*"
"53","Cell-Cell communication",5.19672126165342e-05,0.00221382473054915,0.557332238758646,-1.90602704089058,95,"down","**"
"54","EPH-Ephrin signaling",5.3912852921551e-05,0.00223642066672791,0.557332238758646,-1.90426894924462,81,"down","**"
"55","Collagen chain trimerization",0.000499430777272817,0.0135265460057375,0.477270815362862,-1.89938634081238,38,"down","*"
"56","Creation of C4 and C2 activators",0.00118208299238371,0.0249634435573396,0.45505986738723,-1.89830704335548,9,"down","*"
"57","Signaling by NTRK1 (TRKA)",2.1719490006002e-05,0.00105113281841547,0.575610261071129,-1.89394849429777,104,"down","**"
"58","Signaling by BMP",0.00132967543804492,0.0273348322352067,0.45505986738723,-1.89284371676334,23,"down","*"
"59","IRAK4 deficiency (TLR2/4)",0.00166846169932409,0.0322986377294155,0.45505986738723,-1.885970198006,10,"down","*"
"60","Caspase activation via extrinsic apoptotic signalling pathway",0.00152106068994679,0.0306349847494908,0.45505986738723,-1.88030124090758,24,"down","*"
"61","MET activates PTK2 signaling",0.00190173284353289,0.0348524650058005,0.45505986738723,-1.87841321578578,28,"down","*"
"62","NOTCH4 Intracellular Domain Regulates Transcription",0.00210857097769968,0.0365538088148981,0.431707695803346,-1.87788809302889,16,"down","*"
"63","MyD88 deficiency (TLR2/4)",0.00144871369200676,0.0295207184783483,0.45505986738723,-1.87669144143835,9,"down","*"
"64","Trafficking and processing of endosomal TLR",0.00186302035744541,0.0348524650058005,0.45505986738723,-1.87629365333341,10,"down","*"
"65","Extra-nuclear estrogen signaling",0.000174623945277713,0.00633830351375199,0.518848077743792,-1.86799566408737,67,"down","**"
"66","Regulation of actin dynamics for phagocytic cup formation",0.000428029330490128,0.0127399831663816,0.49849310876659,-1.86684072123554,55,"down","*"
"67","Integrin signaling",0.00105980033046165,0.0233731310745326,0.45505986738723,-1.86610493514434,26,"down","*"
"68","Signal Transduction",4.55184678483066e-26,1.05739400811616e-22,1.32671609800481,-1.85808806603888,1901,"down","***"
"69","FCGR3A-mediated phagocytosis",0.000500767523242971,0.0135265460057375,0.477270815362862,-1.85270815136377,55,"down","*"
"70","Leishmania phagocytosis",0.000500767523242971,0.0135265460057375,0.477270815362862,-1.85270815136377,55,"down","*"
"71","Parasite infection",0.000500767523242971,0.0135265460057375,0.477270815362862,-1.85270815136377,55,"down","*"
"72","Regulation of cytoskeletal remodeling and cell spreading by IPP complex components",0.00224250972232859,0.0380244531749586,0.431707695803346,-1.85137080399446,7,"down","*"
"73","MET promotes cell motility",0.000757831444679596,0.0179636984284766,0.477270815362862,-1.84961155860508,39,"down","*"
"74","Signaling by NTRKs",3.66106725224026e-05,0.00160465268433097,0.557332238758646,-1.84562284334404,123,"down","**"
"75","RHO GTPases Activate WASPs and WAVEs",0.000971101322766562,0.0219016346872497,0.477270815362862,-1.84538838232367,33,"down","*"
"76","Muscle contraction",1.16391376153221e-05,0.000675942917009833,0.593325476396405,-1.83648107656743,149,"down","***"
"77","Metabolism of fat-soluble vitamins",0.00130804652038427,0.0271302863111845,0.45505986738723,-1.83438801190595,31,"down","*"
"78","Defective B3GALTL causes Peters-plus syndrome (PpS)",0.00112857325021296,0.0242747746318954,0.45505986738723,-1.8322655062351,33,"down","*"
"79","Signaling by NOTCH1",0.000428512251885942,0.0127399831663816,0.49849310876659,-1.82315851124032,65,"down","*"
"80","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux",0.00155059492462657,0.0306349847494908,0.45505986738723,-1.82139099795837,31,"down","*"
"81","Potential therapeutics for SARS",0.000558902417904923,0.0145207489478578,0.477270815362862,-1.81556246333186,71,"down","*"
"82","Diseases associated with glycosaminoglycan metabolism",0.00195777717213548,0.0352551656656645,0.431707695803346,-1.80924941074302,36,"down","*"
"83","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants",0.000587580887257267,0.0145207489478578,0.477270815362862,-1.80764562033772,50,"down","*"
"84","Constitutive Signaling by NOTCH1 PEST Domain Mutants",0.000587580887257267,0.0145207489478578,0.477270815362862,-1.80764562033772,50,"down","*"
"85","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer",0.000587580887257267,0.0145207489478578,0.477270815362862,-1.80764562033772,50,"down","*"
"86","Signaling by NOTCH1 PEST Domain Mutants in Cancer",0.000587580887257267,0.0145207489478578,0.477270815362862,-1.80764562033772,50,"down","*"
"87","Signaling by NOTCH1 in Cancer",0.000587580887257267,0.0145207489478578,0.477270815362862,-1.80764562033772,50,"down","*"
"88","Terminal pathway of complement",0.000608219468987209,0.0148725665942872,0.477270815362862,1.79678749676933,5,"up","*"
"89","Peptide hormone metabolism",0.0011262769473864,0.0242747746318954,0.45505986738723,-1.79651400636527,54,"down","*"
"90","Signaling by TGFB family members",0.000181659000256801,0.00649221319379306,0.518848077743792,-1.78155951678218,94,"down","**"
"91","EPHB-mediated forward signaling",0.00176684856916234,0.0339205721170588,0.45505986738723,-1.78070715086397,39,"down","*"
"92","Fcgamma receptor (FCGR) dependent phagocytosis",0.000458140074735741,0.0130885561458791,0.49849310876659,-1.77801548776545,76,"down","*"
"93","N-glycan trimming in the ER and Calnexin/Calreticulin cycle",0.00191662702626161,0.0348524650058005,0.45505986738723,-1.77694667159045,33,"down","*"
"94","Infectious disease",7.47221568892141e-11,1.23985407466889e-08,0.839088935621274,-1.77301441280762,670,"down","***"
"95","Anti-inflammatory response favouring Leishmania parasite infection",0.000220208232080765,0.00752270181064142,0.518848077743792,-1.77049983760434,111,"down","**"
"96","Leishmania parasite growth and survival",0.000220208232080765,0.00752270181064142,0.518848077743792,-1.77049983760434,111,"down","**"
"97","Signaling by Interleukins",3.30961354541873e-07,2.77563539108775e-05,0.674962860011025,-1.76885991879403,365,"down","***"
"98","Developmental Biology",3.93180166894226e-11,7.3808261640257e-09,0.851339057116899,-1.76456400781654,733,"down","***"
"99","Immune System",2.14597951153816e-19,1.24627760132579e-16,1.14219120216838,-1.76041511816147,1697,"down","***"
"100","Nuclear Events (kinase and transcription factor activation)",0.00155614644874727,0.0306349847494908,0.45505986738723,-1.75969435951444,54,"down","*"
"101","Synthesis of substrates in N-glycan biosythesis",0.00160773089747929,0.0313845283600368,0.45505986738723,-1.75651313132616,54,"down","*"
"102","Glycosaminoglycan metabolism",0.000462015326716353,0.0130885561458791,0.49849310876659,-1.75494421816716,105,"down","*"
"103","Signaling by Nuclear Receptors",1.4638612056514e-05,0.00079082548389028,0.593325476396405,-1.75216535372165,206,"down","***"
"104","Binding and Uptake of Ligands by Scavenger Receptors",0.00283041902326589,0.0459753655583496,0.431707695803346,-1.74796776811993,37,"down","*"
"105","Interleukin-4 and Interleukin-13 signaling",0.000563217050354988,0.0145207489478578,0.477270815362862,-1.73913443124378,89,"down","*"
"106","Oncogenic MAPK signaling",0.00124570480836708,0.0260700204489795,0.45505986738723,-1.73286047651548,77,"down","*"
"107","Clathrin-mediated endocytosis",0.000101990782381677,0.00401567097411248,0.538434096309916,-1.73147373760183,126,"down","**"
"108","SARS-CoV Infections",0.000115077870807886,0.00439857118099039,0.538434096309916,-1.72852155279495,133,"down","**"
"109","Regulation of PTEN gene transcription",0.00308441715741755,0.0494144900460757,0.431707695803346,-1.72849615525006,53,"down","*"
"110","VEGFA-VEGFR2 Pathway",0.000395173376502091,0.0122398367148581,0.49849310876659,-1.7266565432893,91,"down","*"
"111","ADORA2B mediated anti-inflammatory cytokines production",0.000818360470142461,0.0188638172106013,0.477270815362862,-1.71910975736638,79,"down","*"
"112","ER-Phagosome pathway",0.00208970416754534,0.036499118655698,0.431707695803346,-1.69482203740039,69,"down","*"
"113","Unfolded Protein Response (UPR)",0.00228536614928903,0.0384703301796986,0.431707695803346,-1.68898650077519,83,"down","*"
"114","Chylomicron remodeling",0.000145866220457073,0.00537852746225048,0.518848077743792,-1.68340894369766,3,"down","**"
"115","Signaling by NOTCH",0.000258517139457651,0.00857907592800175,0.49849310876659,-1.6825778464035,161,"down","**"
"116","Signaling by NOTCH4",0.00201986671382522,0.0358179418031754,0.431707695803346,-1.6820225658035,73,"down","*"
"117","Disease",1.54259002571656e-13,5.9723943828993e-11,0.943632225232838,-1.67867297361605,1273,"down","***"
"118","G alpha (12/13) signalling events",0.00215959410384159,0.0368877728178237,0.431707695803346,-1.65763407012966,70,"down","*"
"119","Vesicle-mediated transport",8.67630606479505e-08,8.3979412452162e-06,0.704975715167238,-1.65113914788787,597,"down","***"
"120","Beta-catenin independent WNT signaling",0.000437887260489964,0.0127399831663816,0.49849310876659,-1.65095379495999,134,"down","*"
"121","ESR-mediated signaling",0.000808580468201064,0.0188638172106013,0.477270815362862,-1.63422729146665,148,"down","*"
"122","Programmed Cell Death",0.000390448227312842,0.0122398367148581,0.49849310876659,-1.63313262786481,164,"down","*"
"123","Diseases of signal transduction by growth factor receptors and second messengers",3.42719228590916e-05,0.00159266749355368,0.557332238758646,-1.62037546668917,347,"down","**"
"124","Toll-like Receptor Cascades",0.000661047382289446,0.0158618960145315,0.477270815362862,-1.61810344039422,133,"down","*"
"125","Rho GTPase cycle",0.00189989569754092,0.0348524650058005,0.45505986738723,-1.59672497853491,123,"down","*"
"126","Signaling by GPCR",1.69579460736779e-06,0.000112552310654725,0.643551836150722,-1.59583354783999,536,"down","***"
"127","G alpha (s) signalling events",0.00199221777989568,0.0355993992515205,0.431707695803346,-1.59547208286385,104,"down","*"
"128","Transcriptional regulation by RUNX2",0.00274598369572359,0.0449219727124358,0.431707695803346,-1.59516987362941,106,"down","*"
"129","Cytokine Signaling in Immune system",1.48954367691776e-07,1.38408398459198e-05,0.690132458796796,-1.59420595312048,710,"down","***"
"130","Apoptosis",0.00106431558269879,0.0233731310745326,0.45505986738723,-1.59057080659638,154,"down","*"
"131","GPCR downstream signalling",7.156042296699e-06,0.000449283412303561,0.610526878385931,-1.57744456421655,489,"down","***"
"132","PTEN Regulation",0.00268722168173336,0.0442724536643022,0.431707695803346,-1.57568014190653,123,"down","*"
"133","Membrane Trafficking",4.72433365188054e-06,0.000304850752036625,0.610526878385931,-1.54873789368628,562,"down","***"
"134","Cellular responses to external stimuli",8.050483090353e-05,0.00322435727911897,0.538434096309916,-1.51156547964663,463,"down","**"
"135","MAPK family signaling cascades",0.000820165965678315,0.0188638172106013,0.477270815362862,-1.49918653180229,282,"down","*"
"136","RAF/MAP kinase cascade",0.00154048394662633,0.0306349847494908,0.45505986738723,-1.49648919131557,243,"down","*"
"137","MAPK1/MAPK3 signaling",0.00188393530587554,0.0348524650058005,0.45505986738723,-1.48518267133084,249,"down","*"
"138","GPCR ligand binding",0.0026574870618536,0.044095303176328,0.431707695803346,-1.45974663007038,257,"down","*"
"139","Cellular responses to stress",0.000316548285520895,0.0102130787120144,0.49849310876659,-1.44898981798747,455,"down","*"
"140","Asparagine N-linked glycosylation",0.00239451234802059,0.0400176416147614,0.431707695803346,-1.44073132226631,268,"down","*"
"141","Neuronal System",0.00192041133049611,0.0348524650058005,0.45505986738723,-1.44020017671812,293,"down","*"
"142","Metabolism of proteins",5.88244174779978e-07,4.2702850562934e-05,0.659444398037935,-1.41671750201543,1616,"down","***"
"143","Post-translational protein modification",1.25390308817004e-05,0.000710443139955852,0.593325476396405,-1.40577642452754,1147,"down","***"
"144","Transport of small molecules",0.00212986004445642,0.0366493695057204,0.431707695803346,-1.35226416876923,561,"down","*"
"145","Adaptive Immune System",0.00284995808885163,0.0459753655583496,0.354819512103747,-1.32527823916819,637,"down","*"
